Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE P W DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISOLYTE P W DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE 56 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
ISOLYTE P with 5% Dextrose provides electrolyte replacement and caloric supplementation. Dextrose is metabolized to carbon dioxide and water, yielding energy. Electrolytes are essential for maintaining osmotic balance, acid-base equilibrium, and normal cellular function.
PLASMA-LYTE 56 is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and electrolyte balance. It expands extracellular fluid volume and improves circulation by increasing plasma volume. The solution's electrolyte composition mimics plasma, helping to correct electrolyte deficits and acid-base disturbances.
Intravenous infusion. Adult dose: 1000-2000 mL over 24 hours, adjusted based on fluid and electrolyte needs. Typical rate: 125-150 mL/hour.
Intravenous infusion; dose depends on fluid and electrolyte needs; typical adult rate: 100-200 mL/hour.
None Documented
None Documented
Dextrose: rapid clearance, half-life ~1.5-2 hours in normoglycemic patients; prolonged in renal impairment or diabetes. Electrolytes follow homeostatic regulation with no defined terminal half-life.
Not applicable as a fixed value; infused electrolytes distribute and are eliminated according to individual ion kinetics (e.g., sodium t½ ~30 min, chloride t½ ~1–2 h) with rapid redistribution.
Renal excretion of free water and electrolytes; dextrose is metabolized to CO2 and water, with negligible biliary or fecal elimination. Approximately 50-70% of infused water is excreted renally within 24 hours, adjusted by ADH and renal function.
Primarily renal; >90% of infused electrolytes are excreted unchanged in urine; fecal elimination negligible (<5%).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution